Pangali Forward P/E 111 Inc (YI)

Simbol lan logo merek 111, Inc (YI)

111, Inc. integrates telemedicine with retail, radically simplifying access to treatment. The company's forward P/E shift confirms this technological breakthrough, with the metric currently standing at 0.00. Meanwhile, the business relies on a B2B ecosystem amid strict government price regulations. The company has now transitioned from extensive expansion toward logistics optimization and the pursuit of real profitability.

Pangali Forward P/E 111, Inc (YI): kanggo periode 04.07.2022 - 12.11.2026

Rincian analitis perusahaan 111, Inc.

- kuotasi lan prakiraan analis:
Rega saham 111, Inc.|YI - Prakiraan konsensus analis
- rincian kapitalisasi pasar:
Kapitalisasi pasar 111, Inc|YI - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- informasi kapitalisasi buku:
Nilai Akuntansi Saham 111, Inc.|YI - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku 111.com.cn|YI - Aset Agregat Perusahaan
- indikator beban kredit lan likuiditas emiten:
Rasio Utang marang Ekuitas 111, Inc.|YI - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas 111, Inc.|YI - Gunggung utang perusahaan|Utang-utang marang aset resik 111, Inc.|YI - Kewajiban jangka dawa perusahaan|Utang jangka cendhak 111, Inc.|Koefisien jangkoan perantara 111.com.cn
- rincian bathi lan kelipatan pasar:
YI - Bathi resik perusahaan|Bathi forward 111, Inc.|YI - Pangali P/E|Pangali mangsa ngarep rega marang bathi 111, Inc.|YI - Pangali PEG|Pangali EV/EBITDA 111, Inc|YI - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku 111, Inc.|YI - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan 111.com.cn|YI - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep 111, Inc.
Analisis fundamental perusahaan:111 Inc., YI
Produk asli 111.com.cn

Forward P/E is calculated as the ratio of the current market share price to the expected earnings per share in the next period, measuring market expectations regarding future business efficiency. Amid low margins and regulatory risks in China, the projected P/E of 111, Inc. allows for an assessment of the company's resilience to operating losses, helping investors find a balance between risk and return.

Pesaing 111, Inc.

Pangali Forward P/E CVS|Pangali Forward P/E McKesson Corp (MCK)|Pangali Forward P/E COR (AmerisourceBergen)|CAH - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi Henry Schein, Inc. (HSIC)|PBH - Pangali Forward P/E|wellgisticshealth.com - Kapitalisasi marang proyeksi bathi|RDGT (China Jo-Jo Drugstores, Inc.) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep Universe Pharmacy (UPC)|Pangali Forward P/E Biodexa Pharma|Prakiraan rega marang bathi HKPD (Hong Kong Pharma Digital)|Prakiraan rega marang bathi usbimi.com BIMI|Kapitalisasi marang proyeksi bathi CJJD|WBA - Prakiraan rega marang bathi